Mechanism Selective NNMT inhibition, proposed to preserve intracellular NAD+/SAM and reduce fat-cell lipogenesis demonstrated in mice, not humans
Still, because NAD+ injections are a relatively novel therapy, patients are monitored for any unexpected reactions
Tesamorelin was developed specifically for HIV-associated lipodystrophy, which describes the abnormal fat accumulation (particularly visceral adipose tissue, or VAT) that occurs in patients on antiretroviral therapy
Starting with a small dose allows the body to adjust to the medication
The more meaningful risks are compounding quality, sterile technique, and the possibility of masking an undiagnosed condition behind a monthly energy boost
full-length hGH engages the GHR/IGF-1/anabolic pathway simultaneously